Role of magnetic resonance imaging in the detection of local prostate cancer recurrence after external beam radiotherapy and radical prostatectomy

Clinical Oncology

Volumn 25, Issue 4, 2013, Pages 252-264

  Wu, L M ^a   Xu, J R ^a   Gu, H Y ^a   Hua, J ^a   Zhu, J ^a   Chen, J ^a   Zhang, W ^a   Hu, J ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Meta analysis; MRI; Recurrent prostate cancer; Systematic review

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; EMBASE; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MEDLINE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; TRANSRECTAL ULTRASONOGRAPHY;

COMBINED MODALITY THERAPY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 84875366272     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2012.11.010     Document Type: Article

References (42)

1. Guidelines on prostate cancer 2009, European Association of Urology, European Association of Urology, Arnhem.
2. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002, 53(5):1097-1105.
3. Aus G., Abbou C.C., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 2005, 48:546-551.
4. Pound C.R., Partin A.W., Eisenberger M.A., Chan D.W., Pearson J.D., Walsh P.C. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999, 281:1591-1597.
5. Kramer S., Gorich J., Gottfried H.W., et al. Sensitivity of computed tomography in detecting local recurrence of prostatic carcinoma following radical prostatectomy. Br J Radiol 1997, 70:995-999.
6. Raj G.V., Partin A.W., Polascik T.J. Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy. Cancer 2002, 94:987-996.
7. Hara T., Kosaka N., Kishi H. PET imaging of prostate cancer using carbon-11- choline. J Nucl Med 1998, 39:990-995.
8. Silverman J.M., Krebs T.L. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy. Am J Roentgenol 1997, 168:379-385.
9. Westphalen A.C., Reed G.D., Vinh P.P., Sotto C., Vigneron D.B., Kurhanewicz J. Multiparametric 3T endorectal mri after external beam radiation therapy for prostate cancer. J Magn Reson Imaging 2012, 36(2):430-437.
10. Hricak H., Schoder H., Pucar D., et al. Advances in imaging in the postoperative patient with a rising prostate-specific antigen level. Semin Oncol 2003, 30:616-634.
11. Amsellem-Ouazana D., Younes P., Conquy S., et al. Negative prostatic biopsies in patients with a high risk of prostate cancer: is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. Eur Urol 2005, 47:582-586.
12. Whiting P., Rutjes A.W., Reitsma J.B., et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003, 3:25.
13. Pakos E.E., Kyzas P.A., Ioannidis J.P. Prognostic significance of TP53 tumor suppressor gene expression and mutations in human osteosarcoma: a meta-analysis. Clin Cancer Res 2004, 10(18 Pt 1):6208-6214.
14. Harbord R.M., Deeks J.J., Egger M., Whiting P., Sterne J.A. A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics 2007, 8(2):239-251.
15. Deeks J.J., Macaskill P., Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 2005, 58(9):882-893.
16. Rutter C.M., Gatsonis C.A. A hierarchical regression approach to metaanalysis of diagnostic test accuracy evaluations. Stat Med 2001, 20(19):2865-2884.
17. McKenna D.A., Coakley F.V., Westphalen A.C., et al. Prostate cancer: role of pretreatment MR in predicting outcome after external-beam radiation therapy-initial experience. Radiology 2008, 247(1):141-146.
18. Kumbhani S.R., Coakley F.V., McCulloch C.E., et al. Endorectal MRI after radiation therapy: questioning the sextant analysis. J Magn Reson Imaging 2011, 33(5):1086-1090.
19. Kim C.K., Park B.K., Lee H.M. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3 T diffusion-weighted MRI. J Magn Reson Imaging 2009, 29(2):391-397.
20. Akin O., Gultekin D.H., Vargas H.A., et al. Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results. Eur Radiol 2011, 21(9):1970-1978.
21. Yakar D., Hambrock T., Huisman H., et al. Feasibility of 3 T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy. Invest Radiol 2010, 45(3):121-125.
22. Arumainayagam N., Kumaar S., Ahmed H.U., et al. Accuracy of multiparametric magnetic resonance imaging in detecting recurrent prostate cancer after radiotherapy. BJU Int 2010, 106(7):991-997.
23. Parivar F., Hricak H., Shinohara K., et al. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. Urology 1996, 48(4):594-599.
24. Ben Cheikh A., Girouin N., Ryon-Taponnier P., et al. MR detection of local prostate cancer recurrence after transrectal high-intensity focused US treatment: preliminary results. J Radiol 2008, 89:571-577.
25. Huch Böni R.A., Meyenberger C., Pok Lundquist J., Trinkler F., Lütolf U., Krestin G.P. Value of endorectal coil versus body coil MRI for diagnosis of recurrent pelvic malignancies. Abdom Imaging 1996, 21(4):345-352.
26. Moman M.R., van den Berg C.A., Boeken Kruger A.E., et al. Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences. Int J Radiat Oncol Biol Phys 2010, 76(3):741-746.
27. Tamada T., Sone T., Jo Y., et al. Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors. AJR Am J Roentgenol 2011, 197(2):408-414.
28. Panebianco V., Sciarra A., Lisi D., et al. Prostate cancer: 1HMRS-DCEMR at 3 T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP). Eur J Radiol 2011 Feb 15, (Epub ahead of print).
29. Kara T., Akata D., Akyol F., Karçaaltincaba M., özmen M. The value of dynamic contrast-enhanced MRI in the detection of recurrent prostate cancer after external beam radiotherapy: correlation with transrectal ultrasound and pathological findings. Diagn Interv Radiol 2011, 17(1):38-43.
30. Westphalen A.C., Coakley F.V., Roach M., McCulloch C.E., Kurhanewicz J. Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection. Radiology 2010, 256(2):485-492.
31. Westphalen A.C., Kurhanewicz J., Cunha R.M., et al. T2-weighted endorectal magnetic resonance imaging of prostate cancer after external beam radiation therapy. Int Braz J Urol 2009, 35(2):171-180.
32. Cirillo S., Petracchini M., Scotti L., et al. Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging. Eur Radiol 2009, 19(3):761-769.
33. Sciarra A., Panebianco V., Salciccia S., et al. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 2008, 54(3):589-600.
34. Haider M.A., Chung P., Sweet J., et al. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys 2008, 70(2):425-430.
35. Casciani E., Polettini E., Carmenini E., et al. Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy. AJR Am J Roentgenol 2008, 190(5):1187-1192.
36. Drudi F.M., Giovagnorio F., Carbone A., et al. Transrectal colour Doppler contrast sonography in the diagnosis of local recurrence after radical prostatectomy - comparison with MRI. Ultraschall Med 2006, 27(2):146-151.
37. Pucar D., Shukla-Dave A., Hricak H., et al. Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience. Radiology 2005, 236(2):545-553.
38. Sella T., Schwartz L.H., Swindle P.W., et al. Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 2004, 231(2):379-385.
39. Rouvière O., Valette O., Grivolat S., et al. Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor - correlation with biopsy findings. Urology 2004, 63(5):922-927.
40. Coakley F.V., Teh H.S., Qayyum A., et al. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Radiology 2004, 233(2):441-448.
41. Sala E., Eberhardt S.C., Akin O., et al. Endorectal MR imaging before salvage prostatectomy: tumor localization and staging. Radiology 2006, 238(1):176-183.
42. Pucar D., Hricak H., Shukla-Dave A., et al. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and stepsection pathology evidence. Int J Radiat Oncol Biol Phys 2007, 69:62-69.